These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 19460268)
1. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin. Dalgic N; Ceylan Y; Sancar M; Telhan L; Kafadar I; Cavusoglu H; Ceylan O; Hasim O Ann Trop Paediatr; 2009 Jun; 29(2):141-7. PubMed ID: 19460268 [TBL] [Abstract][Full Text] [Related]
2. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Karaiskos I; Galani L; Baziaka F; Giamarellou H Int J Antimicrob Agents; 2013 Jun; 41(6):499-508. PubMed ID: 23507414 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. Ho YH; Wang LS; Chao HJ; Chang KC; Su CF J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636 [TBL] [Abstract][Full Text] [Related]
5. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis. De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii. Chusri S; Sakarunchai I; Kositpantawong N; Panthuwong S; Santimaleeworagun W; Pattharachayakul S; Singkhamanan K; Doi Y Int J Antimicrob Agents; 2018 Apr; 51(4):646-650. PubMed ID: 29241820 [TBL] [Abstract][Full Text] [Related]
7. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis. Fulnecky EJ; Wright D; Scheld WM; Kanawati L; Shoham S J Infect; 2005 Dec; 51(5):e249-51. PubMed ID: 15913780 [TBL] [Abstract][Full Text] [Related]
8. Intraventricular CNS treatment with Colistin-Tigecycline combination: A case series. Tsolaki V; Karvouniaris M; Manoulakas E; Kotlia P; Karadontas V; Fotakopoulos G; Zakynthinos E; Makris D J Crit Care; 2018 Oct; 47():338-341. PubMed ID: 30097260 [TBL] [Abstract][Full Text] [Related]
9. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin. Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Karaiskos I; Galani L; Baziaka F; Katsouda E; Ioannidis I; Andreou A; Paskalis H; Giamarellou H Int J Antimicrob Agents; 2013 May; 41(5):480-3. PubMed ID: 23566531 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Fernandez-Viladrich P; Corbella X; Corral L; Tubau F; Mateu A Clin Infect Dis; 1999 Apr; 28(4):916-7. PubMed ID: 10825065 [No Abstract] [Full Text] [Related]
12. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Lee CH; Tang YF; Su LH; Chien CC; Liu JW Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240 [TBL] [Abstract][Full Text] [Related]
13. Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Fotakopoulos G; Makris D; Chatzi M; Tsimitrea E; Zakynthinos E; Fountas K Acta Neurochir (Wien); 2016 Mar; 158(3):603-10; discussion 610. PubMed ID: 26801512 [TBL] [Abstract][Full Text] [Related]
14. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377 [TBL] [Abstract][Full Text] [Related]
15. The 21st-century challenge to neurocritical care: the rise of the superbug Acinetobacter baumannii. A meta-analysis of the role of intrathecal or intraventricular antimicrobial therapy in reduction of mortality. Mohammed N; Savardekar AR; Patra DP; Narayan V; Nanda A Neurosurg Focus; 2017 Nov; 43(5):E8. PubMed ID: 29088961 [TBL] [Abstract][Full Text] [Related]
17. Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature. Al Shirawi N; Memish ZA; Cherfan A; Al Shimemeri A J Chemother; 2006 Oct; 18(5):554-8. PubMed ID: 17127235 [TBL] [Abstract][Full Text] [Related]
18. Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis. Patel JA; Pacheco SM; Postelnick M; Sutton S Am J Health Syst Pharm; 2011 Aug; 68(16):1527-31. PubMed ID: 21817084 [TBL] [Abstract][Full Text] [Related]
19. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. Ng J; Gosbell IB; Kelly JA; Boyle MJ; Ferguson JK J Antimicrob Chemother; 2006 Nov; 58(5):1078-81. PubMed ID: 16916866 [TBL] [Abstract][Full Text] [Related]
20. [Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumanii]. Alaoui SY; Nejmi SE; Chakir AA; Hmamouchi B; Chlilek A Ann Fr Anesth Reanim; 2011 Nov; 30(11):854-5. PubMed ID: 21981848 [No Abstract] [Full Text] [Related] [Next] [New Search]